Market Tracker

07/27 5:11pm ET

MannKind Corp (NASDAQ:MNKD)

1.00
Delayed Data
As of 3:59pm ET
 +0.0093 / +0.94%
Today’s Change
0.64
Today|||52-Week Range
5.03
-31.03%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close0.99
Today’s open0.99
Day’s range0.98 - 1.02
Volume1,426,073
Average volume (3 months)5,392,499
Market cap$473.2M
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.18%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LBIOLion Biotechnologies...+0.45+5.48%
VNDAVanda Pharmaceutical...+0.09+0.80%
AIMTAimmune Therapeutics...+0.37+3.18%
SPPISpectrum Pharmaceuti...+0.33+5.07%
Data as of 3:59pm ET, 07/27/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts